Skip to content

DR.SIGRID MUSCH

Active Private limited companyfounded 2007active for 19 yearsAalstersesteenweg 46, 9400 NinoveKBO/BCE: BE 0887.072.423

Lifetime

19 annual accounts with figures on one time axis
peak of €110,962 in 2021
€34,189▼ 49.0%
lowest -€3,110 in 2008
€5,913▼ 80.8%
peak of €313,510 in 2022
€253,386▼ 12.8%
€305,824▲ 14.6%
Board1 name since 2021
1 director
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from €67,058 to €34,189Result from €30,793 to €5,913Dividend €43,000Equity from €290,473 to €253,386

Key points

from the 2025 annual accounts

Equity

€253,386 ▼ 12.8%
290,4732024+5,913Profit-43,000Dividend253,3862025

DR.SIGRID MUSCH paid out €43,000 in dividends. That is 727% of the 2025 profit.

Filings

19 annual accounts since 2007
AprilJune31 JulyOctober2010201520202025

Six of the last ten came late. The 2022 accounts came in latest, 31 days after the end of the period.

Position in the sector

€5,913

Lower net result than 86% of companies in human health. The sector median is €59,520, over 21,355 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,057 companies had the same profile as DR.SIGRID MUSCH has now. Each dot stands for 16 companies, two years later.

95.9%
were still trading
3.7%
stopped another way
0.4%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,057 companies, not a prediction for DR.SIGRID MUSCH. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0887072423
resigns as manager reappointed as director · Discharge granted to (manager) · General meeting of 09-02-2023 · Gazette deed
Incorporation published on 15-02-2007 · Gazette deed
2 establishments registered Ninove and Haaltert
All 29 events

Comparable companies

same main activity, similar in size and age
Company
DR.SIGRID MUSCH Ninove €559,210 €34,189 45.3% -
IMMO WIJNENDALE Torhout €473,828 €34,440 3.9% -
DR PATRICIA GOLSTEIN Ixelles €484,137 €38,812 55.9% -
Dr. Karin GOVAERTS, huisarts Linter €672,258 €38,556 48.6% -
DR. MARINO GLABEKE Middelkerke €461,132 €34,723 88.8% -
Docteur TIRMARCHE La Louvière €472,733 €28,571 98.7% -
SPRL ENGLEBERT-QUISQUATER Ciney €667,268 €41,540 68.7% -

These companies have the same main activity as DR.SIGRID MUSCH: general medical practice (NACE 86210). They are comparable in size and age: total assets between €461,000 and €672,000, founded between 2004 and 2010.

Official details

Source: KBO
Status
Active since 07-02-2007Normal situation
Activity
General medical practiceNACE 86210and 1 other
Establishment units
2.240.576.1759400 Ninove, since 07-02-2007
2.240.576.5719450 Haaltert, since 07-02-2007
Financial year end
31 December
Peppol
Reachable since 06-11-2025
Company details

Annual accounts 2025

≈ €110,000estimated
€559,210▲ 0.3%
Filing
Filed on 31-08-2026
Financials

Insights on DR.SIGRID MUSCH

DR.SIGRID MUSCH files the micro format. That format states no turnover. The gross margin rose from €23,229 in 2007 to €34,189 in 2025.

The balance sheet grew most from 2016 to 2018 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR.SIGRID MUSCH

What is the company number of DR.SIGRID MUSCH?
The company number of DR.SIGRID MUSCH is 0887.072.423. The VAT number is the same number with BE in front: BE 0887.072.423.
Where is DR.SIGRID MUSCH based?
The registered office is at Aalstersesteenweg 46, 9400 Ninove.Company details
What does DR.SIGRID MUSCH do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR.SIGRID MUSCH?
DR.SIGRID MUSCH is a private limited company (BV).
When was DR.SIGRID MUSCH founded?
DR.SIGRID MUSCH was founded on 07-02-2007.
Is DR.SIGRID MUSCH still active?
Yes, DR.SIGRID MUSCH is an active enterprise in the KBO register.
What is the turnover of DR.SIGRID MUSCH?
The turnover in financial year 2025 is about €110,000. This figure is estimated from the gross margin of €34,189 and 47 comparable companies (NACE 86). It probably lies between €76,000 and €150,000.Financials
Is DR.SIGRID MUSCH profitable?
In financial year 2025, DR.SIGRID MUSCH made a profit of €5,913.
Where can I find the annual accounts of DR.SIGRID MUSCH?
DR.SIGRID MUSCH filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR.SIGRID MUSCH due?
DR.SIGRID MUSCH must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.